Ether

Ether

SCHEMBL3899534

CCOCC.Oc1ccc(Sc2ccc(O)cc2)cc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.64
LTA4H P09960 3/20 0.42
ESR1 P03372 5/20 0.41
ESR2 Q92731 3/20 0.41
CA2 P00918 3/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
CA7 P43166 1/20 0.41
LMNA P02545 5/20 0.40
MAPT P10636 4/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CYP3A4 P08684 3/20 0.38
ALOX15 P16050 3/20 0.38
CYP2D6 P10635 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38
CYP1A2 P05177 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroquinone SCHEMBL60032 0.85 LTA4H (0.52) LTA4HESR1ESR2CA2CA12
Hydroquinone SCHEMBL925171 0.85 LTA4H (0.52) LTA4HESR1ESR2CA2CA12
Hydroquinone SCHEMBL8536783 0.85 LTA4H (0.52) LTA4HESR1ESR2CA2CA12
SCHEMBL23906768 0.85 LTA4H (0.52) NR1H2LTA4HLMNAMAPTMEN1
SCHEMBL14368588 0.81 LTA4H (0.68) NR1H2LTA4HLMNAMAPTMEN1
Hydroquinone SCHEMBL21647162 0.80 LTA4H (0.48) LTA4HESR1ESR2CA2CA12
Hydroquinone SCHEMBL7891403 0.80 LTA4H (0.48) LTA4HESR1ESR2CA2CA12
Methoxymethane SCHEMBL10979307 0.80 NR1H2 (0.78) NR1H2LTA4HESR1ESR2CA2
Hydroquinone SCHEMBL9418610 0.80 LTA4H (0.48) LTA4HESR1ESR2CA2CA12
SCHEMBL29726 0.80 NR1H2 (1.00) NR1H2ESR1ESR2CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009072002-A2 BISPHENOLS IN CANCER THERAPY UNIVERSITY OF MANITOBA (US) 2009-06-11 WO disclosed